Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas A McCormick

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Physical Review. E, Statistical, Nonlinear, and Soft Matter Physics|February 3, 2004
Lattice study of a Janus interfaceThomas A McCormick
BMJ Open Diabetes Research & Care|May 8, 2024
Cardiovascular and mortality benefits of sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide 1 receptor agonists as third-step glucose-lowering medicine in patients with type 2 diabetes: a retrospective cohort analysisThomas A McCormick, Jason Kramer, Elizabeth G Liles, et al.
The Journal of Allergy and Clinical Immunology. in Practice|November 10, 2021
Population-Based Incidence of New Ampicillin, Cephalexin, Cefaclor, and Sulfonamide Antibiotic "Allergies" in Exposed Individuals with and without Preexisting Ampicillin, Cephalexin, or Cefaclor "Allergies"Eric Macy, William W Crawford, Myngoc T Nguyen, et al.
JAMA Network Open|April 29, 2021
Association Between Removal of a Warning Against Cephalosporin Use in Patients With Penicillin Allergy and Antibiotic PrescribingEric Macy, Thomas A McCormick, John L Adams, et al.
EGEMS (Washington, DC)|September 17, 2019
Age-Dependent Hemoglobin A1c Therapeutic Targets Reduce Diabetic Medication Changes in the ElderlyThomas A McCormick, John L Adams, Eric A Lee, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Physical Review. E, Statistical, Nonlinear, and Soft Matter Physics|February 3, 2004
Lattice study of a Janus interfaceThomas A McCormick
BMJ Open Diabetes Research & Care|May 8, 2024
Cardiovascular and mortality benefits of sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide 1 receptor agonists as third-step glucose-lowering medicine in patients with type 2 diabetes: a retrospective cohort analysisThomas A McCormick, Jason Kramer, Elizabeth G Liles, et al.
The Journal of Allergy and Clinical Immunology. in Practice|November 10, 2021
Population-Based Incidence of New Ampicillin, Cephalexin, Cefaclor, and Sulfonamide Antibiotic "Allergies" in Exposed Individuals with and without Preexisting Ampicillin, Cephalexin, or Cefaclor "Allergies"Eric Macy, William W Crawford, Myngoc T Nguyen, et al.
JAMA Network Open|April 29, 2021
Association Between Removal of a Warning Against Cephalosporin Use in Patients With Penicillin Allergy and Antibiotic PrescribingEric Macy, Thomas A McCormick, John L Adams, et al.
EGEMS (Washington, DC)|September 17, 2019
Age-Dependent Hemoglobin A1c Therapeutic Targets Reduce Diabetic Medication Changes in the ElderlyThomas A McCormick, John L Adams, Eric A Lee, et al.
Pageof 1